What motivates doctors to prescribe branded medications?

Those who receive speaker fees and meals are less likely to opt for generics, according to study

Paying doctors speaker fees or shouting them a meal appears to have paid off for the marketers of brand name gabapentinoids, US research suggests.


Doctors who received pharma company payments were almost twice as likely to prescribe the branded versions of  the drugs than those who received no money, says a research letter in JAMA Internal Medicine.

Researchers from Yale University and the University of Connecticut examined the association between pharma payments and physician prescribing of gabapentinoids.